Rock Springs Capital Management as of June 30, 2021
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 156 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Agilon Health (AGL) | 5.6 | $284M | 7.0M | 40.57 | |
Zai Lab Adr (ZLAB) | 3.5 | $180M | 1.0M | 176.99 | |
Agios Pharmaceuticals (AGIO) | 2.8 | $142M | 2.6M | 55.11 | |
Humana (HUM) | 2.6 | $134M | 303k | 442.72 | |
Align Technology (ALGN) | 2.3 | $115M | 188k | 611.00 | |
IDEXX Laboratories (IDXX) | 2.2 | $114M | 180k | 631.55 | |
Insulet Corporation (PODD) | 2.2 | $112M | 409k | 274.51 | |
Intuitive Surgical Com New (ISRG) | 2.2 | $110M | 120k | 919.64 | |
Neurocrine Biosciences (NBIX) | 2.0 | $99M | 1.0M | 97.32 | |
Novavax Com New (NVAX) | 1.9 | $97M | 455k | 212.31 | |
UnitedHealth (UNH) | 1.9 | $96M | 240k | 400.44 | |
Argenx Se Sponsored Adr (ARGX) | 1.9 | $95M | 315k | 301.07 | |
Immunocore Hldgs Ads (IMCR) | 1.8 | $94M | 2.4M | 39.05 | |
Hca Holdings (HCA) | 1.8 | $93M | 450k | 206.74 | |
Nevro (NVRO) | 1.7 | $88M | 531k | 165.79 | |
Freshpet (FRPT) | 1.6 | $83M | 507k | 162.96 | |
Invitae (NVTAQ) | 1.5 | $78M | 2.3M | 33.73 | |
Blueprint Medicines (BPMC) | 1.4 | $71M | 809k | 87.96 | |
EXACT Sciences Corporation (EXAS) | 1.4 | $71M | 570k | 124.31 | |
Beigene Sponsored Adr (BGNE) | 1.4 | $69M | 200k | 343.19 | |
Graphite Bio | 1.3 | $66M | 2.2M | 30.73 | |
Aclaris Therapeutics (ACRS) | 1.3 | $66M | 3.8M | 17.56 | |
Pacira Pharmaceuticals (PCRX) | 1.2 | $62M | 1.0M | 60.68 | |
Edwards Lifesciences (EW) | 1.2 | $60M | 582k | 103.57 | |
Phreesia (PHR) | 1.2 | $59M | 960k | 61.30 | |
Horizon Therapeutics Pub L SHS | 1.2 | $59M | 625k | 93.64 | |
Verve Therapeutics (VERV) | 1.1 | $58M | 963k | 60.25 | |
Eargo | 1.1 | $58M | 1.5M | 39.91 | |
Teleflex Incorporated (TFX) | 1.0 | $52M | 130k | 401.79 | |
Mirati Therapeutics | 1.0 | $52M | 319k | 161.53 | |
Alnylam Pharmaceuticals (ALNY) | 1.0 | $51M | 300k | 169.52 | |
Prothena Corp SHS (PRTA) | 1.0 | $49M | 950k | 51.41 | |
Arvinas Ord (ARVN) | 1.0 | $48M | 626k | 77.00 | |
Ultragenyx Pharmaceutical (RARE) | 0.9 | $44M | 465k | 95.35 | |
Karuna Therapeutics Ord | 0.9 | $44M | 387k | 113.99 | |
Acadia Healthcare (ACHC) | 0.9 | $44M | 700k | 62.75 | |
Health Catalyst (HCAT) | 0.9 | $44M | 785k | 55.51 | |
Lifestance Health Group (LFST) | 0.8 | $42M | 1.5M | 27.86 | |
Shockwave Med | 0.8 | $42M | 220k | 189.73 | |
Bright Health Group | 0.8 | $41M | 2.4M | 17.16 | |
Penumbra (PEN) | 0.8 | $40M | 148k | 274.06 | |
Ardelyx (ARDX) | 0.8 | $40M | 5.2M | 7.58 | |
Seagen | 0.8 | $40M | 250k | 157.88 | |
Biogen Idec (BIIB) | 0.8 | $39M | 114k | 346.27 | |
Covetrus | 0.8 | $39M | 1.5M | 27.00 | |
Encompass Health Corp (EHC) | 0.8 | $39M | 500k | 78.03 | |
Novocure Ord Shs (NVCR) | 0.8 | $39M | 175k | 221.82 | |
Mersana Therapeutics (MRSN) | 0.8 | $39M | 2.8M | 13.58 | |
Accolade (ACCD) | 0.7 | $36M | 665k | 54.31 | |
Evolent Health Cl A (EVH) | 0.7 | $36M | 1.7M | 21.12 | |
Boston Scientific Corporation (BSX) | 0.7 | $34M | 800k | 42.76 | |
Ppd | 0.6 | $31M | 675k | 46.09 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.6 | $31M | 234k | 131.55 | |
Kymera Therapeutics (KYMR) | 0.6 | $30M | 627k | 48.50 | |
Irhythm Technologies (IRTC) | 0.6 | $30M | 448k | 66.35 | |
Cullinan Oncology (CGEM) | 0.5 | $28M | 1.1M | 25.75 | |
Adaptive Biotechnologies Cor (ADPT) | 0.5 | $27M | 650k | 40.86 | |
Mirum Pharmaceuticals (MIRM) | 0.5 | $26M | 1.5M | 17.29 | |
Pulmonx Corp (LUNG) | 0.5 | $26M | 593k | 44.12 | |
Allakos (ALLK) | 0.5 | $26M | 306k | 85.37 | |
Cerevel Therapeutics Hldng I (CERE) | 0.5 | $26M | 1.0M | 25.62 | |
Madrigal Pharmaceuticals (MDGL) | 0.5 | $26M | 263k | 97.41 | |
Sarepta Therapeutics (SRPT) | 0.5 | $26M | 329k | 77.74 | |
Bolt Biotherapeutics (BOLT) | 0.5 | $25M | 1.6M | 15.46 | |
Epizyme | 0.5 | $25M | 3.0M | 8.31 | |
Guardant Health (GH) | 0.5 | $25M | 200k | 124.19 | |
ACADIA Pharmaceuticals (ACAD) | 0.5 | $24M | 1.0M | 24.39 | |
CONMED Corporation (CNMD) | 0.4 | $22M | 163k | 137.43 | |
Oak Street Health | 0.4 | $22M | 375k | 58.57 | |
Travere Therapeutics (TVTX) | 0.4 | $22M | 1.5M | 14.59 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $22M | 920k | 23.64 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $21M | 254k | 83.44 | |
Abcam Ads | 0.4 | $21M | 1.1M | 19.04 | |
Intersect Ent | 0.4 | $21M | 1.2M | 17.09 | |
Rigel Pharmaceuticals Com New | 0.4 | $21M | 4.8M | 4.34 | |
Sierra Oncology Com New | 0.4 | $20M | 1.0M | 19.47 | |
Dex (DXCM) | 0.4 | $20M | 46k | 427.00 | |
Innovage Hldg Corp (INNV) | 0.4 | $19M | 903k | 21.31 | |
Translate Bio | 0.4 | $19M | 693k | 27.54 | |
Amarin Corp Spons Adr New (AMRN) | 0.4 | $19M | 4.3M | 4.38 | |
Biomea Fusion (BMEA) | 0.4 | $18M | 1.2M | 15.61 | |
Spruce Biosciences (SPRB) | 0.4 | $18M | 1.6M | 11.21 | |
Rocket Pharmaceuticals (RCKT) | 0.4 | $18M | 403k | 44.29 | |
Kura Oncology (KURA) | 0.3 | $17M | 817k | 20.85 | |
Atea Pharmaceuticals (AVIR) | 0.3 | $17M | 791k | 21.48 | |
Cytokinetics Note 4.000%11/1 (Principal) | 0.3 | $17M | 8.0M | 2.07 | |
Dynavax Technologies Corp Com New (DVAX) | 0.3 | $17M | 1.7M | 9.85 | |
Relay Therapeutics (RLAY) | 0.3 | $17M | 450k | 36.59 | |
Nkarta (NKTX) | 0.3 | $16M | 498k | 31.69 | |
Chiasma | 0.3 | $15M | 3.3M | 4.73 | |
Prometheus Biosciences | 0.3 | $15M | 596k | 24.56 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $15M | 425k | 34.42 | |
Applied Therapeutics (APLT) | 0.3 | $15M | 702k | 20.78 | |
Mereo Biopharma Group Ads (MREO) | 0.3 | $14M | 4.5M | 3.17 | |
Essa Pharma Com New (EPIX) | 0.3 | $14M | 503k | 28.57 | |
Inozyme Pharma (INZY) | 0.3 | $14M | 840k | 17.04 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $14M | 535k | 25.93 | |
Gamida Cell SHS | 0.3 | $14M | 2.1M | 6.41 | |
Spero Therapeutics (SPRO) | 0.3 | $14M | 966k | 13.96 | |
Akero Therapeutics (AKRO) | 0.3 | $13M | 529k | 24.81 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $13M | 313k | 41.05 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.2 | $13M | 16M | 0.81 | |
Macrogenics (MGNX) | 0.2 | $12M | 456k | 26.86 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $12M | 606k | 19.58 | |
Galapagos Nv Spon Adr (GLPG) | 0.2 | $11M | 165k | 68.89 | |
Paratek Pharmaceuticals | 0.2 | $11M | 1.7M | 6.82 | |
Aeglea Biotherapeutics | 0.2 | $11M | 1.6M | 6.96 | |
Prelude Therapeutics (PRLD) | 0.2 | $11M | 382k | 28.63 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $11M | 573k | 18.62 | |
Reneo Pharmaceuticals (RPHM) | 0.2 | $11M | 1.1M | 9.33 | |
Compugen Ord (CGEN) | 0.2 | $10M | 1.2M | 8.28 | |
West Pharmaceutical Services (WST) | 0.2 | $10M | 29k | 359.09 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $10M | 786k | 12.96 | |
Theravance Biopharma (TBPH) | 0.2 | $10M | 688k | 14.52 | |
Apellis Pharmaceuticals Call Option (APLS) | 0.2 | $10M | 158k | 63.20 | |
Orion Acquisition Corp Unit 02/19/2026 | 0.2 | $9.9M | 1.0M | 9.92 | |
Amicus Therapeutics (FOLD) | 0.2 | $9.8M | 1.0M | 9.64 | |
Chinook Therapeutics | 0.2 | $9.6M | 682k | 14.12 | |
Shattuck Labs (STTK) | 0.2 | $9.1M | 314k | 28.99 | |
F-star Therapeutics | 0.2 | $9.1M | 1.1M | 8.59 | |
Day One Biopharmaceuticals I (DAWN) | 0.2 | $8.5M | 374k | 22.77 | |
Nurix Therapeutics (NRIX) | 0.2 | $8.4M | 315k | 26.53 | |
Constellation Pharmceticls I | 0.2 | $8.4M | 247k | 33.80 | |
Fibrogen (FGEN) | 0.2 | $8.3M | 313k | 26.63 | |
Kinnate Biopharma | 0.2 | $7.7M | 332k | 23.28 | |
Athira Pharma (ATHA) | 0.2 | $7.7M | 748k | 10.24 | |
Fusion Pharmaceuticals | 0.2 | $7.7M | 948k | 8.08 | |
Phasebio Pharmaceuticals | 0.1 | $6.9M | 1.8M | 3.72 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $6.8M | 694k | 9.74 | |
Design Therapeutics (DSGN) | 0.1 | $6.6M | 332k | 19.89 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $6.6M | 1.5M | 4.26 | |
Trillium Therapeutics Com New | 0.1 | $6.1M | 629k | 9.70 | |
Fate Therapeutics (FATE) | 0.1 | $6.1M | 70k | 86.79 | |
Atai Life Sciences Nv SHS (ATAI) | 0.1 | $5.8M | 315k | 18.50 | |
Galera Therapeutics (GRTX) | 0.1 | $5.6M | 568k | 9.83 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.1 | $5.4M | 761k | 7.09 | |
Acelrx Pharmaceuticals | 0.1 | $5.2M | 3.8M | 1.38 | |
Atreca Cl A Com (BCEL) | 0.1 | $3.9M | 460k | 8.52 | |
Tempest Therapeutics (TPST) | 0.1 | $3.5M | 310k | 11.18 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.3M | 309k | 10.53 | |
Poseida Therapeutics I (PSTX) | 0.1 | $2.9M | 290k | 10.02 | |
Retrophin Note 2.500% 9/1 (Principal) | 0.1 | $2.8M | 3.3M | 0.85 | |
Nuvation Bio Com Cl A (NUVB) | 0.0 | $2.2M | 242k | 9.31 | |
Eucrates Biomedical Acqu Cor Unit 10/23/2027 | 0.0 | $2.1M | 206k | 10.20 | |
Fs Development Corp Ii Com Cl A | 0.0 | $2.1M | 209k | 9.98 | |
Turmeric Acquisition Corp Unit 10/08/2025 | 0.0 | $2.1M | 206k | 10.06 | |
Jiya Acquisition Corp Com Cl A | 0.0 | $2.0M | 206k | 9.94 | |
Population Health Invs Co In Unit 99/99/9999 | 0.0 | $2.0M | 201k | 10.15 | |
Helix Acquisition Corp Com Cl A | 0.0 | $1.6M | 155k | 10.35 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.95 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.93 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.35 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.1M | 1.0M | 1.09 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $866k | 500k | 1.73 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $348k | 134k | 2.60 | |
Aerpio Pharmaceuticals | 0.0 | $225k | 133k | 1.69 |